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Abstract
Sclerosing angiomatoid nodular transformation (SANT)
is a benign, proliferative vascular lesion affecting the
spleen. Few reports detailing the cross sectional and PET
appearance of this lesion are available, and the lesion’s
behavior with
99mTc-sulfur colloid scintigraphy is previ-
ously unreported. Sclerosing nodular transformation of
the spleen shows increased tracer accumulation on
positron emission tomography, and a central scar-like
appearance with an enhancing capsule and radiating
septae on CT and MR studies that reflects the gross and
histopathological features of the lesion may be visible. An
understanding of this pathological finding may allow
prospective recognition of the sclerosing nodular trans-
formationofthespleenoncrosssectionalimagingstudies.
Key words: Sclerosing angiomatoid nodular
transformation—Spleen—Proliferation—Mass—
Vascular lesion—Sulfur colloid—Positron emission
tomography
Splenic lesions are commonly incidentally encountered
during abdominal cross sectional imaging studies. The
majority of such lesions are benign. Occasionally solid,
vascular splenic lesions may be identiﬁed and can prove
difﬁcult to characterize with non-invasive imaging.
Awareness of the imaging appearance and differential
diagnosis of rare vascular splenic lesions, and, in par-
ticular, recognition of certain imaging features that may
suggest a speciﬁc diagnosis for these uncommon lesions,
may facilitate proper patient management.
Report of case
An 80-year-old white man with a history of indolent
myelodysplastic syndrome (MDS), melanoma, basal cell
carcinoma, and squamous cell carcinoma underwent an
oncologic whole body 2-[
18F]-Fluoro-2-Deoxy-D-Glucose
positron emission computed tomography-CT (FDG-PET
CT) survey which revealed a solitary 8.5 cm hypermeta-
bolicsplenic masswitha peak standarduptakevalue of4.5
(Fig. 1). Subsequent contrast-enhanced CT confirmed the
presence of an irregular, solid and low attenuation splenic
lesion (Fig. 2A–D) without features that would allow the
diagnosis of a benign lesion. Based on the patient’s history
of myelodysplasia, the incidental nature of the detection of
the lesion, and limited reports suggesting an association
betweenmyelodysplasiaandextramedullaryhematopoiesis
[1], MRI examination was recommended to assess for the
presence of iron within the lesion (Fig. 3). Magnetic reso-
nance imaging of the mass (Fig. 3A, B) showed predomi-
n a n t l yd e c r e a s e ds i g n a lo nT 1 -a n dT 2 - w e i g h t e di m a g e s
associated with several areas of hyperintensity on both Correspondence to: Michael B. Gotway; email: mgotway@esmil.net
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Imaging
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DOI: 10.1007/s00261-009-9584-xsequences. Following the intravenous administration of
gadolinium contrast (Gd-DPTA; gadopentetate dimeglu-
mine, Magnevist, Bayer Healthcare), MR imaging
(Fig. 3C–F) showed peripheral nodular enhancement with
enhancing septae and delayed central filling of the lesion.
Opposed-phase imaging (Fig. 3G, H) examination showed
findings suggesting the presence of an iron-containing le-
sion, such as extramedullary hematopoiesis, and confirma-
tion with
99mTc-sulfur colloid scanning was recommended.
99mTc-sulfur colloid single photon emission tomography-
computed tomography (SPECT/CT) scan (Fig. 4)w a s
performed and showed a lack of radiopharmaceutical up-
take,suggestingthatextramedullaryhematopoiesiswasnot
the likely diagnosis. The etiology for the lesion remained
indeterminate and neoplasm could not be excluded.
Following splenectomy, at gross inspection the spleen
was granular and gray–purple with a lobulated 9 cm
mass with hemorrhagic areas measuring 0.1–0.5 cm
(Fig. 5). Histopathological examination of the lesion
(Fig. 6) showed concentric bands of fibrosis surrounding
nodules of splenic white pulp associated with irregular-
shaped vascular spaces lined with plump endothelial cells
that contained numerous erythrocytes compatible with
sclerosing angiomatoid nodular transformation (SANT).
No malignancy was found.
Discussion
The incidental detection of a splenic lesion is not an
uncommon clinical occurrence, and differentiation of
indolent from aggressive splenic lesions on imaging
studies can occasionally be difﬁcult. Fortunately, most
cystic and solid lesions within the spleen in patients
without known primary malignancy are benign, and
neoplasms within the spleen are less common than
benign processes and are often encountered in a known
clinical context, commonly patients with lymphoma or
metastatic disease.
Vascular splenic lesions include both benign and
malignant etiologies, but most of these lesions are non-
hematolymphoid tumors [2]. Non-hematolymphoid tu-
mors arise from the red pulp of the spleen and include
hemangiomas, hamartomas, lymphangiomas, and SANT
[2]. Vascular splenic lesions with variable biological
behavior include littoral cell angioma, hemangioendo-
thelioma, and hemangiopericytoma, whereas angiosar-
coma is a primary, frankly malignant, vascular splenic
neoplasm [2].
Fig. 2. SANT of the spleen: CT findings. Axial unenhanced
(A), arterial phase (B), portal venous phase (C), and delayed
(D) enhanced imaging of the abdomen show that the splenic
lesion is initially isodense or mildly hypodense to normal
spleen (A). Arterial phase imaging (B) shows marked nodular
enhancement of the periphery of the lesion (arrows) with a few
faintly visible septae (arrowheads) penetrating the center of
the lesion from the periphery. The portal venous phase image
(C) again shows the hypervascular rim of the lesion (arrows).
Vague areas of decreased attenuation centrally represent the
fibrosclerotic center of the lesion (when correlated with gross
appearance in Fig. 5). Delayed enhanced imaging (D) shows
that the lesion progressively enhances toward its center,
becoming nearly isodense to the normal spleen. Note, how-
ever, that the central ‘‘scar’’ remains visible (when compared
with gross pathological appearance in Fig. 5).
Fig. 1. SANT of the spleen: 2-[
18F]-Fluoro-2-Deoxy-D-Glu-
cose (FDG-PET) findings. Axial fused image shows intense
tracer activity (standard uptake value = 4.5) within the splenic
lesion.
684 C. Thacker et al.: Sclerosing angiomatoid nodular transformation of the spleenSANT of the spleen is a recently recognized, rare,
benign vascular splenic neoplasm of uncertain etiology,
ﬁrst described in 2004 as a distinct, non-neoplastic vas-
cular splenic lesion by Martel et al. [3]. Prior to 2004,
isolated reports of splenic SANT were described under
various other terms, including splenic hamartomas,
multinodular hemangiomas, cord-capillary hemangioma,
or splenic hemangioendotheliomas [4].
Clinical, pathological, and histopathological
features of splenic SANT
Only a few reports have detailed the clinicopathological
aspects of splenic SANT [3–6]. The few reports detailing
this lesion suggest that splenic SANT is most commonly
encountered in middle-aged adults, with a mean age of
presentation approximating 50 years [4, 7], although a
fairly wide age range for presentation of 22–74 years has
been noted [4]. A female preponderance of cases is de-
scribed, with a female-to-male ratio of 2:1 suggested in
several sources [4, 7]. Most reports indicate that splenic
SANT is clinically silent and is detected incidentally,
usually during laparotomy or imaging studies for unre-
lated reasons.
At gross inspection, patients with splenic SANT often
have a normal-sized or mildly enlarged spleen. The lesion
itself usually appears as solitary, unencapsulated but
circumscribed mass consisting of red or brown nodules
of variable size. The histopathological and immunohis-
tochemical ﬁndings of splenic SANT have been the
subject of several reports [3–10]. At low-power exami-
nation, splenic SANT is composed of multiple, variably
sized, circumscribed and confluent angiomatoid nodules
within a fibrosclerotic stroma containing hemosiderin-
laden macrophages, myofibroblasts, lymphocytes, and
plasma cells [4]. The nodules have a slit-like, vascular
Fig. 3. SANT of the spleen: MR findings. Axial T1-weighted
[TR = 690 ms, TE = 40 ms] (A) and T2-weighted fat satura-
tion [TR = 16000 ms, TE = 91 ms] (B) images show the le-
sion to be predominantly low signal on both sequences, with a
few foci of relatively hyperintense T1- and T2-weighted signal
(arrows) representing foci of hemorrhage. Unenhanced (C)
and arterial (D), venous (E) and delayed (F) enhanced axial
3D T1-weighted gradient echo images with fat saturation
[LAVA, TR = 4.5 ms, TE = 2.2 ms] images show initial in-
tense enhancement of the periphery of the lesion (double
arrow) with progressive appearance of thin enhancing septae
(arrowheads) penetrating the center of the lesion from the
periphery. Areas of nodular enhancement (arrows) correlate
with the presence of angiomatoid nodules (compare with
gross pathological appearance in Fig. 5). Axial in-phase [TR =
180 ms, TE = 2.4 ms] (G) and out-of-phase [TR = 180 ms,
TE = 2.4 ms] (H) images show a progressive signal increase
on the shorter TE sequence (H), consistent with the presence
of iron within the lesion. Pathological analysis shows that iron
within SANT of the spleen is likely due to the presence of
blood products.
C. Thacker et al.: Sclerosing angiomatoid nodular transformation of the spleen 685morphology lined with endothelial cells, pericytes, and
red blood cells. Minimal cellular atypia may be present
within splenic SANT nodules but mitotic figures are rare.
Immunohistochemical analysis of splenic SANT shows
staining with various markers for splenic sinusoidal lin-
ing cells, capillary-like, and venule-like elements [4],
including CD34, CD21, and CD8. CD68 staining is also
typical in splenic SANT, whereas CD21 staining is
characteristically absent.
Imaging features of splenic SANT (Table 1)
Little is known of the typical cross-sectional imaging
features of splenic SANT as fewer than 30 cases have been
reported in the medical literature [7, 11–13], and most
published reports have concentrated on the pathological
aspects of this lesion. The published reports detailing the
cross sectional imaging appearance of splenic SANT are
summarized in Table 1. Li et al. [6] were the first to de-
scribe the CT appearance of SANT. These investigators
indicated that CT showed a lesion with a small focus of
central calcification, initially hypodense on portal phase
imaging, that became progressively homogeneous and
approaching the attenuation of surrounding enlarged
spleen in the late portal venous phase [6]. Subsequent
reports by other investigators have repeatedly described a
lesion that shows a comparatively hypovascular center
with an enhancing rim and radiating vascularized tissue
penetrating from the periphery toward the center of the
lesion; this morphology has been seen on contrast-
enhanced ultrasound [11], CT [7, 12], and MR examina-
tions. When mutiphasic imaging is performed, splenic
Fig. 4. SANT of the spleen:
99mTc-sulfur colloid scan find-
ings. SPECT CT shows normal tracer activity within the liver
and spleen with essentially no activity within the splenic le-
sion, confirming the absence of reticuloendothelial elements
within this abnormality.
Fig. 5. SANT of the spleen: gross pathological findings. Cut
specimen shows a central fibrosclerotic scar (*) with septae
(arrowheads) and hemorrhagic angiomatoid nodules (arrow).
The spleen is visible at the left of the image.
Fig. 6. SANT of the spleen: histopathological findings. Low-
power (A,2 0 9) photomicrograph (hematoxylin and eosin)
shows the formation of fibrous nodules in a background of
splenic red pulp. High-power (B, 4009) photomicrograph
(hematoxylin and eosin) of the central portion of one of the
nodules shows proliferation of irregular vascular spaces lined
by plump endothelial cells, circumscribed by bands of con-
centric fibrosis, and abundant hemosiderin.
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delayed imaging, thought to be the result of contrast pene-
trating the center of the lesion from the vascular rim. This
morphological pattern has been referred to as a ‘‘spoke-
wheel’’ pattern [11, 12]. In those reports detailing radio-
logical and pathological correlation for splenic SANT le-
sions, this ‘‘spoke-wheel’’ morphology corresponds with a
central, stellate fibrous stroma with fibrous septa separating
angiomatoid nodules [7, 11–14].
The presence of signal changes on MR imaging sug-
gesting the presence of iron initially supported the
impression of extramedullary hematopoiesis as the eti-
ology of the splenic lesion in this patient. However, iron
deposition may occur in a number of conditions unre-
lated to extramedullary hematopoiesis, and it is likely
that the hemorrhagic nature of splenic SANT accounts
for this MR imaging appearance.
Only one prior published report of the FDG-PET
behavior of splenic SANT is known [13]. These authors
[13] indicated that splenic SANT shows hypermetabolic
activity on FDG-PET, simulating neoplasm; our lesion
showed similar behavior. The abundance of cells,
including hemosiderin-laden macrophages, myofibro-
blasts, lymphocytes, and plasma cells, may account for
splenic SANT’s FDG avidity.
The
99mTc-sulfurcolloidSPECTCTimagingfindingsof
splenic SANT have not been previously reported. The ab-
sence of reticuloendothelial cells within the SANT lesion
accounts for the lack of uptake of
99mTc-sulfur colloid.
Diagnosis of splenic SANT
Most published reports of SANT of the spleen have
established the diagnosis following splenectomy, al-
though one investigation has shown that the diagnosis of
SANT may be made with percutaneous core biopsy [11].
Nevertheless, percutaneous biopsy of the spleen must be
undertaken with caution as a higher frequency of com-
plication is noted with percutaneous biopsy of vascular
splenic lesions [15]. The gross pathological and radio-
logical correlation of splenic SANT in this report as well
as the published descriptions of the cross-sectional
imaging findings of splenic SANT [7, 11–13] suggest that
the diagnosis of SANT of the spleen may be specifically
offered when contrast-enhanced CT or MR shows a
centrally hypovascular lesion with peripheral enhance-
ment progressively extending toward the center of the
lesion through septae on delayed imaging- the so-called
‘‘spoke-wheel’’ appearance [11, 12]. However, it is likely
that when a vascular splenic lesion is encountered, par-
ticularly when large and bulging the capsular surface of
the spleen, concerns for malignancy and the potential for
splenic rupture will render splenectomy the primary
means by which splenic SANT will be diagnosed and
treated.
Conclusion
SANT of the spleen is a recently described, non-neo-
plastic benign vascular lesion. Few cross-sectional imag-
ing reports have detailed the radiological appearance of
SANT of the spleen, but the literature suggests that a
variably sized lesion, often large, with peripheral
enhancement that progressively ﬁlls in toward the center
of the lesion through radiating septae is a typical
appearance on enhanced ultrasound, CT, and MR stud-
ies. Possibly due to the presence of various inﬂammatory
cells within the lesion, FDG avidity is expected on FDG-
PET studies of SANT of the spleen, whereas, due to the
absence of reticuloendothelial elements, absence of
99mTc-sulfur colloid uptake is observed. The diagnosis of
SANT of the spleen may be established by percutaneous
biopsy, but, due to the potential for an increased rate of
complications when vascular lesions of the spleen un-
dergo percutaneous biopsy and concerns regarding the
possibility of spontaneous rupture of a large vascular
splenic lesion, splenectomy will likely be the means by
which SANT of the spleen is diagnosed and managed.
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